Millennium Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Millennium Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,400	Closed	-$749K	–	7489
2022 Q4	$749K	Sell	30,400 -69,600	-70%	-$2.05M	﹤0.01%	4425
2022 Q3	$1.79M	Buy	+100,000	New	+$1.8M	﹤0.01%	3843

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Millennium Management's INBX Position: Q2 2024 in Review

Millennium Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 25,110 shares — an estimated $878K sold.

Millennium Management first reported a position in INBX in Q3 2020 and held it in 13 quarters. The position peaked at $17.2M in Q4 2022. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Millennium Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Millennium Management sold 25,110 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $878K.
Millennium Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 13 quarters.
Millennium Management's Inhibrx, Inc. Common Stock position peaked at $17.2M in Q4 2022.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.